ICL Group

ICL

Market cap $8.11B

TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release third quarter 2025 results prior to the opening of the TASE market on Wednesday, November 12, 2025. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30.

TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced Anantha Desikan, executive vice president and chief innovation and technology officer of ICL, will be presenting at the Jefferies Industrials Conference 2025 at 4:10 p.m. ET on Wednesday, September 3, 2025. A webcast of the event will be available at https://investors.icl-group.com/reports-news-and-events/default.aspx#events-presentations. A replay will be ava.

TEL AVIV, Israel , Aug. 13, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its second quarter results for the period ending June 30, 2025.

ICL Group Ltd (NYSE:ICL ) Q2 2025 Earnings Conference Call August 6, 2025 8:30 AM ET Company Participants Aviram Lahav - Chief Financial Officer Elad Aharonson - President & CEO Peggy Reilly Tharp - Vice President of Global Investor Relations Conference Call Participants Benjamin M. Theurer - Barclays Bank PLC, Research Division Joel Jackson - BMO Capital Markets Equity Research Kevin Estok - Jefferies LLC, Research Division Operator Good morning, ladies and gentlemen, and welcome to the ICL Second Quarter 2025 Earnings Conference Call.

ICL Group (ICL) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.1 per share a year ago.

TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the second quarter ended June 30, 2025. Consolidated sales were $1.8 billion, up ~$80 million versus the prior year. Operating income was $181 million versus $211 million of operating income in the second quarter of last year, with adjusted operating income of $201 million versus $225 million. For the second quarter, net income attribu.

TEL AVIV, Israel--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release second quarter 2025 results prior to the opening of the TASE market on Wednesday, August 6, 2025. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv).

REHOVOT, Israel , July 8, 2025 /PRNewswire/ -- Evogene Ltd.  (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company utilizing cutting-edge artificial intelligence and predictive biology to drive innovation in life-science product development, today announced the successful completion and closing of the previously disclosed transaction involving the divestiture of the majority of the activities and assets of its ag-biologicals subsidiary, Lavie Bio Ltd.

TEL AVIV, Israel , May 21, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its first quarter results for the period ending March 31, 2025.

ICL sees higher sales across its Industrial Products, Phosphate Solutions and Growing Solutions units in Q1.